Taylor Lorenz @TaylorLorenz
Really bad news about BA.2.75.2 and Evusheld :( How are medically vulnerable people supposed to remain protected when our leaders have dropped all safety measures and we have no tools to protect ourselves? — PolitiTweet.org
Ben Murrell @BenjMurrell
In terms of clinical monoclonal antibodies, Evusheld is completely gone for BA.2.75.2. Sotrovimab looks similar bet… https://t.co/g9M0H2f7Tb